Press Releases
Samsung Biologics continues to build its capabilities and expertise to better serve the biopharma industry
Samsung Biologics will participate in BioJapan, which will be held at Pacifico Yokohama between October 9~11, 2024. PharmTech Japan spoke with Kevin Sharp, Senior Vice President and Head of Global Sales, about the company's CDMO capabilities and its business strategies for the Japanese market.
Samsung Biologics will participate in BioJapan, which will be held at Pacifico Yokohama between October 9~11, 2024. PharmTech Japan spoke with Kevin Sharp, Senior Vice President and Head of Global Sales, about the company's CDMO capabilities and its business strategies for the Japanese market.